Pathogenesis of atopic dermatitis and psoriasis: Focus on the epidermal differentiation complex

Open Dermatology Journal

Volumn 4, Issue 1, 2010, Pages 48-51

  Bergboer, Judith G M ^a   Zeeuwen, Patrick L J M ^a   Schalkwijk, Joost ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atopic dermatitis; Epidermal differentiation complex; Filaggrin; Late cornified envelope; LCE3B C deletion; Psoriasis

Indexed keywords

FILAGGRIN; LATE CORNIFIED ENVELOPE 3 B PROTEIN; LATE CORNIFIED ENVELOPE PROTEIN; PROTEIN DERIVATIVE; PSORIASIS SUSCEPTIBILITY LOCUS PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTICLE; ATOPIC DERMATITIS; CHROMOSOME 1Q; CLINICAL STUDY; EPITHELIUM CELL; GENE DELETION; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HLA SYSTEM; IMMUNOLOGY; LYMPHOCYTE; PATHOGENESIS; PERMEABILITY BARRIER; PRIORITY JOURNAL; PSORIASIS; RISK ASSESSMENT; RISK FACTOR; SKIN PERMEABILITY;

EID: 77953773976     PISSN: None     EISSN: 18743722     Source Type: Journal    
DOI: 10.2174/1874372201004010048     Document Type: Article

References (40)

1. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358(14): 1483-94.
2. Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 2005; 5(9): 699-711.
3. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361(5): 496-509.
4. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004; 4(12): 978-88.
5. Elder JT, Bruce AT, Gudjonsson JE, et al. Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol 2009; [Epub ahead of print].
6. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (epidermal differentiation complex) on human chromosome 1q21. J Invest Dermatol 1996; 106(5): 989-92.
7. Jackson B, Tilli CM, Hardman MJ, et al. Late cornified envelope family in differentiating epithelia-response to calcium and ultraviolet irradiation. J Invest Dermatol 2005; 124(5): 1062-70.
8. Cork MJ, Robinson DA, Vasilopoulos Y, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006; 118(1): 3-21.
9. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008; 17(12): 1063-72.
10. Taieb A. Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 1999; 41(4): 177-80.
11. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38(4): 441-6.
12. Rodriguez E, Baurecht H, Herberich E, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009; 123(6): 1361-70.
13. Huffmeier U, Traupe H, Oji V, et al. Loss-of-function variants of the filaggrin gene are not major susceptibility factors for psoriasis vulgaris or psoriatic arthritis in German patients. J Invest Dermatol 2007; 127(6): 1367-70.
14. Candi E, Schmidt R, Melino G. The cornified envelope: A model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6(4): 328-40.
15. Kezic S, Kemperman PM, Koster ES, et al. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 2008; 128(8): 2117-9.
16. De Fine OF, Wulf HC, Therkildsen P, Poulsen T, Crosby J, Norval M. Urocanic acid isomers: relation to body site, pigmentation, stratum corneum thickness and photosensitivity. Arch Dermatol Res 1997; 289(9): 501-5.
17. Brown SJ, McLean WH. Eczema genetics: current state of knowledge and future goals. J Invest Dermatol 2009; 129(3): 543-52.
18. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120(1): 150-5.
19. Fallon PG, Sasaki T, Sandilands A, et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009; 41(5): 602-8.
20. Ellis CN, Gorsulowsky DC, Hamilton TA, et al. Cyclosporine improves psoriasis in a double-blind study. JAMA 1986; 256(22): 3110-6.
21. Nickoloff BJ. Keratinocytes regain momentum as instigators of cutaneous inflammation. Trends Mol Med 2006; 12(3): 102-6.
22. Hollox EJ, Huffmeier U, Zeeuwen PL, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008; 40(1): 23-5.
23. Capon F, Trembath RC, Barker JN. An update on the genetics of psoriasis. Dermatol Clin 2004; 22(4): 339-47, vii.
24. Nair RP, Stuart P, Henseler T, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 2000; 66(6): 1833-44.
25. Orru S, Giuressi E, Carcassi C, Casula M, Contu L. Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN). Am J Hum Genet 2005; 76(1): 164-71.
26. Giustizieri ML, Mascia F, Frezzolini A, et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001; 107(5): 871-7.
27. Zeeuwen PL, de Jongh GJ, Rodijk-Olthuis D, et al. Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients. PLoS One 2008; 3(6): e2301.
28. Ishida-Yamamoto A, Takahashi H, Iizuka H. Immunoelectron microscopy links molecules and morphology in the studies of keratinization. Eur J Dermatol 2000; 10(6): 429-35.
29. Iizuka H, Takahashi H, Honma M, Ishida-Yamamoto A. Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death. J Dermatol 2004; 31(4): 271-6.
30. Grice K, Sattar H, Baker H, Sharratt M. The relationship of transepidermal water loss to skin temperature in psoriasis and eczema. J Invest Dermatol 1975; 64(5): 313-5.
31. Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol 1994; 130(4): 452-6.
32. Powles AV, Baker BS, Rutman AJ, McFadden JP, Valdimarsson H, Fry L. Epidermal rupture is the initiating factor for the Koebner response in psoriasis. Acta Derm Venereol 1990; 70(1): 35-8.
33. de Cid R, Riveira-Munoz E, Zeeuwen PL, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009; 41(2): 211-5.
34. Huffmeier U, Bergboer JGM, Becker T, et al. Replication of LCE3C-LCE3B CNV as a risk factor for psoriasis. Analysis of interaction with other genetic risk factors. J Invest Dermatol 2009; [Epub ahead of print].
35. Zhang XJ, Huang W, Yang S, et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet 2009; 41(2): 205-10.
36. Huffmeier U, Estivill X, Riveira-Munoz E, et al. Deletion of LCE3C and LCE3B genes at PSORS4 does not contribute to Susceptibility to Psoriatic Arthritis in German patients. Ann Rheum Dis 2009; [Epub ahead of print].
37. Marshall D, Hardman MJ, Nield KM, Byrne C. Differentially expressed late constituents of the epidermal cornified envelope. Proc Natl Acad Sci USA 2001; 98(23): 13031-6.
38. Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324(5931): 1190-2.
39. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007; 449(7164): 804-10.
40. Gao Z, Tseng CH, Strober BE, Pei Z, Blaser MJ. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One 2008; 3(7): e2719.